Page 3 - Heron Therapeutics Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heron therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heron Therapeutics Company Profile Today - Breaking & Trending Today

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to "Sell"

StockNews.com downgraded shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) from a hold rating to a sell rating in a research report report published on Friday morning. Other analysts have also recently issued research reports about the company. Cantor Fitzgerald reaffirmed an overweight rating on shares of Heron Therapeutics in a research report on Monday, […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , Adam Morgan , Securities Exchange Commission , Cantor Fitzgerald , Heron Therapeutics Company Profile , Heron Therapeutics Inc , Needham Company , Commonwealth Equity Services , American International Group Inc , Heron Therapeutics , Free Report , Get Free Report , Director Adam Morgan , Exchange Commission , International Group , Equity Services , Kantonalbank Zurich Cantonalbank , Arizona State Retirement System , State Retirement System , Heron Therapeutics Daily , Nasdaq Hrtx , Stocknews Com ,

StockNews.com Lowers Heron Therapeutics (NASDAQ:HRTX) to Sell

StockNews.com lowered shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) from a hold rating to a sell rating in a report published on Wednesday morning. Several other brokerages also recently weighed in on HRTX. Cantor Fitzgerald reissued an overweight rating on shares of Heron Therapeutics in a report on Monday, July 10th. Needham & Company […] ....

San Diego , United States , Adam Morgan , Millennium Management , Jw Asset Management , Jefferies Financial Group Inc , Heron Therapeutics Inc , Needham Company , Heron Therapeutics Company Profile , Cantor Fitzgerald , America Corp , Heron Therapeutics , Free Report , Get Free Report , Director Adam Morgan , Street Corp , Financial Group , Heron Therapeutics Daily , Nasdaq Hrtx , Stocknews Com ,

Heron Therapeutics (NASDAQ:HRTX) Downgraded to "Sell" at StockNews.com

StockNews.com cut shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) from a hold rating to a sell rating in a research note published on Wednesday morning. HRTX has been the topic of several other research reports. Needham & Company LLC reiterated a buy rating and issued a $5.00 price objective on shares of Heron Therapeutics […] ....

New York , United States , San Diego , Adam Morgan , York State Common Retirement Fund , Heron Therapeutics Inc , Investment Partners , Securities Exchange Commission , Heron Therapeutics Company Profile , Cheyne Capital Management United Kingdom , Needham Company , Cantor Fitzgerald , Cm Management , Heron Therapeutics , Free Report , Get Free Report , Director Adam Morgan , Exchange Commission , Capital Management United Kingdom , Capital Management , Heron Therapeutics Daily , Nasdaq Hrtx , Stocknews Com ,

StockNews.com Lowers Heron Therapeutics (NASDAQ:HRTX) to Sell

StockNews.com Lowers Heron Therapeutics (NASDAQ:HRTX) to Sell
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Hong Kong , Adam Morgan , Needham Company , Topco Ltd , Securities Exchange Commission , Heron Therapeutics Inc , Y Intercept Hong Kong Ltd , Cantor Fitzgerald , Heron Therapeutics Company Profile , Wells Fargo Company , Heron Therapeutics , Get Free Report , Therapeutics Trading Down , Director Adam Morgan , Exchange Commission , Heron Therapeutics Daily ,

Heron Therapeutics (NASDAQ:HRTX) Posts Quarterly Earnings Results, Misses Expectations By $0.12 EPS

Heron Therapeutics (NASDAQ:HRTX – Get Free Report) posted its quarterly earnings data on Monday. The biotechnology company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.12), reports. Heron Therapeutics had a negative return on equity of 1,666.38% and a negative net margin of 115.80%. The company had revenue of $31.76 […] ....

San Diego , United States , Adam Morgan , Needham Company , Heron Therapeutics Inc , Bridgefront Capital , York Mellon Corp , Metlife Investment Management , Vanguard Group Inc , Blackrock Inc , Cantor Fitzgerald , Securities Exchange Commission , Heron Therapeutics Company Profile , Heron Therapeutics , Get Free Report , Director Adam Morgan , Exchange Commission , New York Mellon Corp , Life Investment Management , Heron Therapeutics Daily , Nasdaq Hrtx ,